Poor quality of sleep is associated with incident motoric cognitive risk syndrome, but not prevalent motor cognitive risk syndrome.

A sleep-mood intervention improves insomnia symptoms in university students but has little impact on their mental health and quality of life.

There is an inverse association between serum carotenoid levels and adult migraine risk, according to study findings.

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.

For individuals with Alzheimer disease (AD), the emergence of psychosis is associated with elevations in levels of plasma tau phosphorylated at threonine 181 (p-tau181).

RNA COVID-19 vaccination during pregnancy is not associated with an increased risk of adverse pregnancy outcomes.

Chronic loneliness is associated with increased risk of stroke after adjustment for depressive symptoms and social isolation.

The US Supreme Court on Thursday struck down a controversial settlement that drug maker Purdue Pharma had reached with victims of the opioid epidemic.

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

The FDA has expanded the approval of Lumryz (sodium oxybate) extended-release oral suspension to include treatment of pediatric narcolepsy.

Disease-modifying therapy (DMT) use for multiple sclerosis (MS) in pregnancy is associated with certain adverse outcomes.

For men, high levels of physical activity and fitness are associated with reduced risk of amyotrophic lateral sclerosis (ALS).